Alembic Pharma bags USFDA nod for cardiovascular disease drug Ticagrelor in two strengths Ruchika Sharma2 May 2025 2:46 PM ISTVadodara: Alembic Pharmaceuticals Limited has announced that the US Food & Drug Administration (USFDA) has given final approval to the...
Stress hyperglycemia ratio closely related to the progression of non target coronary lesions, finds study Dr Riya Dave11 Feb 2025 8:30 AM ISTResearchers have found in a new study that stress hyperglycemia ratio (SHR) is highly correlated with the progression of non-target coronary lesions...
New Study Reveals Best Antithrombotic Regimen for Atrial Fibrillation Post-ACS/PCI: Apixaban and P2Y12 Inhibitor Shine Medha Baranwal15 Nov 2024 9:00 AM ISTUSA: A new study from the AUGUSTUS trial has provided new insights into the most effective antithrombotic strategies for patients with atrial...
High-sensitivity troponin shows promise in diagnosing acute coronary syndrome in primary care settings: Study Dr. Kamal Kant Kohli23 Oct 2024 8:45 AM ISTChest pain is a common but challenging symptom for general practitioners to evaluate, as it can be caused by both serious conditions and more benign...
Shorter Dual Antiplatelet Therapy Reduces Bleeding Risk Without Increasing MACCE in ACS Patients Undergoing PCI: JAMA Dr Riya Dave11 Oct 2024 9:00 AM ISTReducing the duration of dual antiplatelet therapy (DAPT) to 1 month with subsequent monotherapy with a P2Y12 inhibitor was associated with an...
Medical bulletin 26/ September/ 2024 Dr. Bhumika Maikhuri26 Sept 2024 3:00 PM ISTHere are the top medical news for the day:How Do Initial Symptoms of MS Have Impact on Long Run Disability?In a significant advance for multiple...
High Sensitivity Troponin Test Demonstrates Better Diagnostic Accuracy in Acute Coronary Syndrome Cases: Systematic Review Dr. Bhumika Maikhuri26 Sept 2024 8:45 AM ISTHigh-sensitivity troponin shows promise in diagnosing acute coronary syndrome in primary care settings. The findings were published in the Annals of...
Clopidogrel resistance associated with gene polymorphism tied to adverse clinical outcomes following PCI: Study Medha Baranwal9 Aug 2024 9:00 AM ISTNew Delhi: Recent studies have reported a concerning issue in managing Acute Coronary Syndrome (ACS)-clopidogrel resistance. This phenomenon, where...
PAD Patients Less Likely to Receive Statins, Despite Increased Cardiac Event Risk: Study Nidhi Srivastava6 Aug 2024 7:30 PM ISTIndia: A retrospective study published in the Journal of the Association of Physicians of India revealed that patients with Peripheral Arterial...
POST-PCI Trial: Surveillance stress testing at 12 months offers no added benefit in high-risk PCI patients, regardless of ACS status Medha Baranwal8 July 2024 9:00 AM ISTSouth Korea: In the realm of post-percutaneous coronary intervention (PCI) care, the debate over the necessity of routine stress testing continues to...
Routine stress testing after year of high-risk PCI of no added benefit: JAMA Jacinthlyn Sylvia1 July 2024 10:45 AM ISTIn the management of patients with acute coronary syndrome (ACS) who have undergone high-risk percutaneous coronary intervention (PCI), a recent study...
Ticagrelor monotherapy good enough after one month of DAPT among patients after PCI: Lancet Jacinthlyn Sylvia27 April 2024 9:30 AM ISTA recent trial found that patients with acute coronary syndrome (ACS) who have undergone percutaneous coronary intervention (PCI) with stent placement...
